Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma (NCT04903197) | Novartis Pharmaceuticals | 2022-01-24 |
Track Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.